April 8, 2019
Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer
CAMBRIDGE, England–(BUSINESS WIRE)–Metrion Biosciences (“Metrion”), the specialist ion channel contract research and drug discovery company, today announced the appointment of…